Business
Hemogenyx Pharmaceuticals PLC - Issue of Equity
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT ...
About this update from Hemogenyx Pharmaceuticals Plc
[{"type":"text","content":"THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.","length":346,"tagName":"p"},{"type":"text","content":" ","length":10,"tagName":"p"},{"type":"text","content":"LONDON, GB / ACCESS Newswire / December 18, 2025 / Hemogenyx Pharmaceuticals plc","length":80,"tagName":"p"},{"type":"text","content":"("Hemogenyx Pharmaceuticals" or the "Company")","length":66,"tagName":"p"},{"type":"text","content":"Issue of Equity arising from the Exercise of Warrants, Restricted Stock Unit Award and Deed of Variation And Total Voting Rights","length":128,"tagName":"p"},{"type":"text","content":"Introduction","length":12,"tagName":"p"},{"type":"text","content":"Hemogenyx Pharmaceuticals plc (LSE:HEMO) announces that it has issued and allotted an aggregate of 123,377 new Ordinary Shares of 1p each ("Ordinary Shares") in the Company for the reasons set out in this announcement.","length":228,"tagName":"p"},{"type":"text","content":"Warrant Shares","length":14,"tagName":"p"},{"type":"text","content":"The Company has received notices to exercise warrants over 105,556 new Ordinary Shares at an exercise price of £1.80 (the "Warrant Shares") raising £190,000 for the Company.","length":183,"tagName":"p"},{"type":"text","content":"Restricted Stock Units","length":22,"tagName":"p"},{"type":"text","content":"The Company also announces the vesting of 6,000 Restricted Stock Units, the grant of which was announced on 29 October 2025. The Company has therefore issued and allotted an aggregate of 6,000 new Ordinary Shares (the "RSU Shares").","length":242,"tagName":"p"},{"type":"text","content":"Deed of Variation","length":17,"tagName":"p"},{"type":"text","content":"Further, the Company has issued and allotted 11,821 new Ordinary Shares further to obligations imposed on it under the terms of a Deed of Variation entered into by the Company on 16 September 2025 (the "Variation Shares"). The Variation Shares are being issued at a price of £8.84 per Variation Share.","length":311,"tagName":"p"},{"type":"text","...